Risk investigation and intervention study of metabolic syndrome in patients with bipolar disorder

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050345

Enrollment

Unknown

Registered

2021-08-26

Start date

2021-09-30

Completion date

Unknown

Last updated

2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Interventions

Lifestyle intervention group:Tai Ji Chuan, Wuqinxi, healthy and balanced diet

Drug intervention group:Metformin and statins as lipid regulators

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 75 years, male or female; 2.It meets the diagnostic criteria of BD in DSM-5 (which can be divided into two subgroups: BD-I and BD-II); 3.All subjects signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Women in pregnancy or lactation period; 2.Persons with mental retardation or substance abuse; 3.Suffering from serious physical diseases, chronic infections and other mental diseases; 4.Patients are taking nonsteroidal anti-inflammatory drugs, corticosteroids or other immunomodulators.

Design outcomes

Primary

Measure	Time frame
Triglyceride;Llow density lipoprotein cholesterin;High density lipoprotein cholesterol;Tumor necrosis factor;Interleukin-6;Homocysteine;hypersensitivity C-reactive protein;	—

Countries

China

Contacts

Public ContactChen Changhao

Suzhou Second People's Hospital

szeykj2020@126.com+86 13855776989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026